Description

14-Hydroxy-17A-Methylene-3-Oxo-D(17A)-Homo-C,18-Dinor-5β-Card-20(22)-Enolide CAS NO 56993-82-9 is a high-purity, advanced pharmaceutical intermediate belonging to the class of modified cardenolides. This compound is of significant value for its role as a key synthetic precursor in the development of novel steroidal drugs and active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and manufacturers in the pharmaceutical industry for the synthesis of specialized cardiovascular and other therapeutic agents.

Application

• Pharmaceutical Intermediate: A critical building block for the synthesis of novel steroidal drugs and active pharmaceutical ingredients (APIs).
• Cardiovascular Drug Research: Used in the research and development of next-generation cardiotonic and anti-arrhythmic agents.
• Steroid Chemistry: Serves as a versatile precursor in advanced steroid synthesis and molecular modification studies.
• Biochemical Research: Employed in academic and industrial laboratories for investigating steroidal pathways and receptor interactions.
• Process Development: Utilized in scaling up and optimizing synthetic routes for complex steroidal molecules.
• Reference Standard: Can be supplied as a high-purity analytical standard for quality control and method validation.

Basic Information

Product Name	14-Hydroxy-17A-Methylene-3-Oxo-D(17A)-Homo-C,18-Dinor-5β-Card-20(22)-Enolide
CAS No.	56993-82-9
Molecular Formula	C₂₄H₃₄O₄
Molecular Weight	386.53 g/mol
Synonyms	14-Hydroxy-17α-methylen-3-oxo-D-homo-18-nor-5β-carda-20(22)-enolide; 17α-Methylene-14-hydroxy-D-homo-18-nor-5β-carda-20(22)-enolide-3-one; 14-Hydroxy-17α-methylene-3-oxo-D-homo-18-nor-5β,14β-card-20(22)-enolide; Modified Cardenolide Intermediate; D-Homo-18-Norcardenolide Derivative; 56993-82-9; SCHEMBL23545427
EINECS	Contact for details

Quality Control

Our 14-Hydroxy-17A-Methylene-3-Oxo-D(17A)-Homo-C,18-Dinor-5β-Card-20(22)-Enolide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (IR, NMR), to ensure it meets the high standards required for pharmaceutical R&D and synthesis. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.